ursolic acid has been researched along with Cancer of Mouth in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karthik, M; Manoharan, S; Muralinaidu, R | 1 |
| Chen, CF; Chen, WK; Chiang, JH; Chiu, HY; Huang, HJ; Juan, YN; Lu, CC; Tsai, SC; Way, TD; Yang, JS | 1 |
| Bai, LY; Chin, HK; Chiu, CF; Chung, JG; Feng, CH; Hsiao, YT; Lee, SL; Lin, CW; Lin, ZY; Liu, YC; Weng, JR; Wu, CY | 1 |
| Lu, M; Ma, X; Xiang, G; Yang, G; Yang, T; Zhang, W | 1 |
4 other study(ies) available for ursolic acid and Cancer of Mouth
| Article | Year |
|---|---|
Ursolic acid-loaded chitosan nanoparticles suppress 7,12-dimethylbenz(a)anthracene-induced oral tumor formation through their antilipid peroxidative potential in golden Syrian hamsters.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogenesis; Carcinoma; Chitosan; Cricetinae; Humans; Lipid Peroxidation; Mesocricetus; Mouth Neoplasms; Nanoparticles; Ursolic Acid | 2023 |
Ursolic acid elicits intrinsic apoptotic machinery by downregulating the phosphorylation of AKT/BAD signaling in human cisplatin‑resistant oral cancer CAR cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-Associated Death Protein; Biomarkers, Tumor; Caspases; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Humans; Membrane Potential, Mitochondrial; Mouth Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Triterpenes; Tumor Cells, Cultured; Ursolic Acid | 2018 |
Ursolic acid induces apoptosis and autophagy in oral cancer cells.
Topics: Angiogenesis Inhibitors; Apoptosis; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Mouth Neoplasms; NF-kappa B; Signal Transduction; Triterpenes; Ursolic Acid | 2019 |
In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Area Under Curve; Biological Availability; Carcinoma, Squamous Cell; Cholesterol Esters; Drug Delivery Systems; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Liposomes; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Mouth Neoplasms; Polyethylene Glycols; Solubility; Triterpenes; Ursolic Acid; Xenograft Model Antitumor Assays | 2014 |